SEC Form 4 · accession 0001127602-16-039363
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paris Panayiotopoulos
Officer — President and CEO · Director
Period of report
Feb 1, 2016
Accepted (ET)
Feb 3, 2016 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2016 | P | 61,099 | $4.91 | A | 61,099 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchase was made pursuant to the terms of his employment agreement, as summarized in the Current Report on Form 8-K filed on December 18, 2015.